171 related articles for article (PubMed ID: 15783063)
1. Bioadhesive dosage forms for esophageal drug delivery.
Batchelor H
Pharm Res; 2005 Feb; 22(2):175-81. PubMed ID: 15783063
[TBL] [Abstract][Full Text] [Related]
2. Strategies and therapeutic opportunities for the delivery of drugs to the esophagus.
Zhang L; Russell D; Conway BR; Batchelor H
Crit Rev Ther Drug Carrier Syst; 2008; 25(3):259-304. PubMed ID: 18540840
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a bioadhesive drug delivery system targeted to oesophageal tissue.
Batchelor HK; Tang M; Dettmar PW; Hampson FC; Jolliffe IG; Craig DQ
Eur J Pharm Biopharm; 2004 Mar; 57(2):295-8. PubMed ID: 15018987
[TBL] [Abstract][Full Text] [Related]
4. Polymers for mucoadhesive drug delivery system: a current status.
Asane GS; Nirmal SA; Rasal KB; Naik AA; Mahadik MS; Rao YM
Drug Dev Ind Pharm; 2008 Nov; 34(11):1246-66. PubMed ID: 18720139
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity.
Smart JD
Crit Rev Ther Drug Carrier Syst; 2004; 21(4):319-44. PubMed ID: 15638469
[TBL] [Abstract][Full Text] [Related]
6. Oral local drug delivery and new perspectives in oral drug formulation.
Paderni C; Compilato D; Giannola LI; Campisi G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):e25-34. PubMed ID: 22771408
[TBL] [Abstract][Full Text] [Related]
7. An overview of recent patents on composition of mucoadhesive drug delivery systems.
Bruschi ML; de Francisco LM; S de Toledo Lde A; Borghi FB
Recent Pat Drug Deliv Formul; 2015; 9(1):79-87. PubMed ID: 25420876
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bioadhesive gels for local action in the esophagus.
Shanthi Chede L; Donovan MD
Int J Pharm; 2023 Jul; 642():123115. PubMed ID: 37302670
[TBL] [Abstract][Full Text] [Related]
9. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors.
Lim AW; Talley NJ; Walker MM; Storm G; Hua S
Drug Deliv; 2023 Dec; 30(1):2219423. PubMed ID: 37344759
[TBL] [Abstract][Full Text] [Related]
10. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
[TBL] [Abstract][Full Text] [Related]
11. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.
Umamaheswari RB; Jain S; Tripathi PK; Agrawal GP; Jain NK
Drug Deliv; 2002; 9(4):223-31. PubMed ID: 12511200
[TBL] [Abstract][Full Text] [Related]
12. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Sudhakar Y; Kuotsu K; Bandyopadhyay AK
J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
[TBL] [Abstract][Full Text] [Related]
13. Novel oral drug formulations. Their potential in modulating adverse effects.
Florence AT; Jani PU
Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
[TBL] [Abstract][Full Text] [Related]
14. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
Lehr CM
Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive oral films: The potential for unmet needs.
Silva BM; Borges AF; Silva C; Coelho JF; Simões S
Int J Pharm; 2015 Oct; 494(1):537-51. PubMed ID: 26315122
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the adhesion of solid oral dosage form coatings to the oesophagus.
Smart JD; Dunkley S; Tsibouklis J; Young S
Int J Pharm; 2015 Dec; 496(2):299-303. PubMed ID: 26453786
[TBL] [Abstract][Full Text] [Related]
18. [Bioadhesives: rationale, state of the art and therapeutic potential].
Martini A; Bonadeo D; Bottoni G; Caramella C; Esposito P; Gazzaniga A; Merlo M; Muggetti L; Orlandi R; Rossi S
Boll Chim Farm; 1995 Dec; 134(11):595-603. PubMed ID: 8820974
[TBL] [Abstract][Full Text] [Related]
19. Floating dosage systems in drug delivery.
Reddy LH; Murthy RS
Crit Rev Ther Drug Carrier Syst; 2002; 19(6):553-85. PubMed ID: 12822735
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
